Fig. 1 |. Efficacy results of the ccRCC cohort.
a, Maximum change from baseline in target lesions. b, Duration of treatment. c, Kaplan–
Meier estimate of progression-free survival. Data in a–c are in the ccRCC cohort; data in 
a includes patients who had a baseline and an evaluable post-baseline assessment (nâ€‰=â€
‰52).
